Female patients may respond better than male patients to certain treatments for heart problems, according to a recent study in the Journal of the American College of Cardiology.
Researchers found that the use of cardiac resynchronization therapy with defibrillator to prevent heart failure is 35 percent more successful in women than in men, they reported.
The study included 1,800 patients, 25 percent of whom were women. Females treated with CRT-D in the study experienced a 72 percent reduction in death and a 70 percent reduction in cardiac failure, compared to a 35 percent chance of avoiding heart failure for men.
Researchers, who stated that similar studies in the past did not show a discrepancy between male and female response to cardiac therapies, said their "finding was unexpected, but extremely important because this is the only heart treatment that is clearly better in women than men."
The difference may have arisen because the genders frequently presented with different types of heart disease - women with non-ischemic heart disease and men with ischemic heart disease, which is better known as coronary artery disease, researchers said.
Both forms of heart disease may result in death and those at risk for the illness should try to obtain life insurance policies to protect their families before developing cardiac-related complications.